Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Azenta (Nasdaq: AZTA) announced its participation in the upcoming 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The company's management team will attend the virtual event scheduled for Tuesday, August 12, 2025. This conference provides an opportunity for investors and analysts to engage with Azenta's leadership through one-on-one meetings.
Azenta (Nasdaq: AZTA) ha annunciato la sua partecipazione al prossimo 10掳 Annuale Needham Virtual MedTech & Diagnostics 1x1 Conference. Il team di gestione dell'azienda parteciper脿 all'evento virtuale previsto per marted矛 12 agosto 2025. Questa conferenza offre un'opportunit脿 a investitori e analisti di interagire con i dirigenti di Azenta tramite incontri individuali.
Azenta (Nasdaq: AZTA) anunci贸 su participaci贸n en la pr贸xima 10陋 Conferencia Anual Virtual Needham MedTech & Diagnostics 1x1. El equipo directivo de la compa帽铆a asistir谩 al evento virtual programado para el martes 12 de agosto de 2025. Esta conferencia brinda una oportunidad para que inversores y analistas se re煤nan personalmente con el liderazgo de Azenta.
Azenta (雮橃姢雼�: AZTA)電� 雼り皜鞓る姅 鞝�10須� 鞐半 雼堧摐頄� 臧靸� 氅旊摐韰岉伂 氚� 歆勲嫧 1雽1 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓 瓴届榿歆勳潃 2025雲� 8鞗� 12鞚� 頇旍殧鞚�鞐� 鞓堨爼霅� 臧靸� 頄夓偓鞐� 彀胳劃頃� 鞓堨爼鞛呺媹雼�. 鞚� 旎嵓霟办姢電� 韴瀽鞛愳檧 鞎犽剱毽姢韸戈皜 Azenta 瓴届榿歆勱臣 鞚茧寑鞚茧 靻岉喌頃� 靾� 鞛堧姅 旮绊殞毳� 鞝滉车頃╇媹雼�.
Azenta (Nasdaq : AZTA) a annonc茅 sa participation 脿 la prochaine 10e conf茅rence annuelle virtuelle Needham MedTech & Diagnostics 1x1. L'茅quipe de direction de l'entreprise assistera 脿 l'茅v茅nement virtuel pr茅vu pour le mardi 12 ao没t 2025. Cette conf茅rence offre aux investisseurs et analystes une occasion d'茅changer en t锚te-脿-t锚te avec les dirigeants d'Azenta.
Azenta (Nasdaq: AZTA) gab seine Teilnahme an der bevorstehenden 10. j盲hrlichen Needham Virtual MedTech & Diagnostics 1x1 Konferenz bekannt. Das Management-Team des Unternehmens wird an der f眉r Dienstag, den 12. August 2025 geplanten virtuellen Veranstaltung teilnehmen. Diese Konferenz bietet Investoren und Analysten die M枚glichkeit, sich in Einzelgespr盲chen mit der F眉hrung von Azenta auszutauschen.
- None.
- None.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor Relations
[email protected]
Sherry Dinsmore
[email protected]
View original content to download multimedia:
SOURCE Azenta